Metabolic Profiles and Fibrosis of Nonalcoholic Fatty Liver Disease
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 19330
Special Issue Editors
Interests: non-acloholic fatty liver disease; obesity; metabolic syndrome; cost-effectiveness analysis; disease screening; epidemiology
Interests: non-acloholic fatty liver disease; obesity; metabolic syndrome; liver fibrosis; epidemiology; preventive medicine
Special Issue Information
Dear Colleagues,
Nonalcoholic fatty liver disease (NAFLD) is a growing problem and is the most common liver disease worldwide. NAFLD wounds progress to non-alcoholic steatohepatitis (NASH) and liver fibrosis, eventually causing liver cancer. Indeed, NAFLD is anticipated to be the main cause of liver cancer in the coming decade. Obesity and metabolic disorder are the main risk factors for NAFLD and liver fibrosis. While treatment drugs remain under Phase II and Phase III clinical trials, urgent updates to NAFLD and NASH care are advocated by many experts. Many clinical care pathways are advocated for emphasizing the importance of this issue.
In this Special Issue, we invite original research articles, reviews, and systematic reviews on all aspects related to NAFLD. Articles on the basic mechanism of NAFLD all the way to clinical observational and intervention studies are welcome. We especially focus on clinical care for the early diagnosis and referral for high-risk populations among the NAFLD group.
Dr. Kuen-Cheh Yang
Dr. Tsung-Po Chen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nonalcoholic fatty liver disease (NAFLD)
- metabolic-associated fatty liver disease (MAFLD)
- advanced fibrosis
- liver cancer
- metabolic syndrome
- non-invasive test (NIT)
- biomarkers